Bringing the fundamentals into focus…
Bringing the fundamentals into focus…
WAY · against 1,336 other Healthcare companies
Ranked #543 of 1,337 · scores higher than 59% of peers
Bars: peers in each 10-point band of the valuation score133 peers with a valuation score of 50–59, including WAY · Click a bar to see the companies
Its metrics sit close to the Healthcare norm.
| Metric | WAY | Peer median | Better than | Position among peers | Weight |
|---|---|---|---|---|---|
| Earnings yieldHigher is better · 1,287 reported | 2.5% | 1.5% | 58% | 30% | |
| EBITDA yieldHigher is better · 1,357 reported | 6.6% | 4.2% | 65% | 50% | |
| Free cash flow yieldHigher is better · 711 reported | 4.6% | -1.0% | 77% | 20% | |
| Book yieldHigher is better · 1,306 reported | 74.3% | 37.9% | 79% | Context only |
| Rank | Company | Market cap | Valuation | Overall |
|---|---|---|---|---|
| 1 | 21.3B HKD (≈$2.7B) | 99 | 68 | |
| 1 | 1.1B HKD (≈$146M) | 99 | 72 | |
| 1 | 14.2B HKD (≈$1.8B) | 99 | 64 | |
| 1 | 52.2B HKD (≈$6.7B) | 99 | 56 | |
| 1 | 3.5B HKD (≈$451M) | 99 | 51 | |
| 543 | 8.3B SEK (≈$826M) | 59 | 65 |
Scores are sector-relative percentiles from the latest snapshot, always calculated against the whole sector: narrowing the comparison group changes who you compare with, not the scores. Missing metrics are left out and the remaining weights rescaled. How we score
| 543 | 16.7B CHF (≈$19.2B) | 59 | 47 |
| 543 | 119.1B USD | 59 | 57 |
| 543 | 11.6B THB (≈$324M) | 59 | 38 |
| 543 | 5.3B USD | 59 | 63 |
| 556 | 105.7B KRW (≈$76M) | 58 | 37 |
| 556 | 2.3B CNY (≈$318M) | 58 | 68 |
| 556 | 19.0B CNY (≈$2.7B) | 58 | 55 |
| 556 | 73.2B SAR (≈$19.8B) | 58 | 56 |